All News
“Rheumatologists should be advising hospital teams caring for patients with all diseases that impact the immune system.”- Dr. Ellen Gravallese, ACR President. #ACR20 @RheumNow
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
“Society cannot function if it is every man for himself. By definition, civilization cannot survive that.” -John Barry from “The Great Influenza.” Vaccinate all your patients, & don’t forget to hold MTX for 2wks after the flu vaccine! #ACR20 @RheumNow @CCalabreseDO @LCalabreseDO https://t.co/IdQ4Zyhq69
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
Rheumies, why should we especially vaccinate our pts with the flu vaccine?
1. Our pts have a higher risk for influenza
2. Our pts have greater morbidity & prolonged viral shedding
3. Vaccination is protective both serologically & clinically
#ACR20 @RheumNow https://t.co/PJCxczJiKg
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
The Use of Tocilizumab and Tofacitinib in Patients with Resolved Hepatitis B Infection: A Case Series https://t.co/2OBy0lxd6b #hepb #tocilizumab #tofacitinib no reactivation in resolved infection
Peter Nash drpnash ( View Tweet)
Liraglutide as a Potential Intra-Articular Treatment for Cartilage Regeneration in Osteoarthritis: In Vitro and In Vivo Studies Supporting a Pro-Chondrogenic Effect https://t.co/T9IqF7E00Z #OA #DMOAD a potential DMOAD in mice
Peter Nash drpnash ( View Tweet)
“We remain cautiously optimistic that we will have a safe, effective vaccine based on animal studies.” Here is an up-to-date list of COVID-19 trials as discussed at #ACR20 by Dr. A. Fauci @RheumNow https://t.co/DAoLGGtw1A
Dr. Rachel Tate uptoTate ( View Tweet)
Fauci: Common endpoints, common parameters provide "bridge" between #COVID19 vaccine trials. "We are cautiously optimistic" for a vaccine "by the end of the calendar year" because of favorable animal studies, though distribution will be later #ACR20 @Rheumnow. https://t.co/vPLEYiGKam
Eric Dein ejdein1 ( View Tweet)
A reminder or the fundamentals to curbing COVID19 per Dr. Anthony Fauci at #ACR20:
1. Everyone needs to wear a mask
2. Maintain 6 feet distance from others
3. Avoid crowds & congregations
4. Outdoor better than indoors
5. Wash your hands frequently
@RheumNow @LCalabreseDO https://t.co/khLS7V2A3b
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
Data from MUSE & TULIP trials of #anifrolumab in #SLE show increased risk of #herpeszoster when compared to placebo. Most HZ events mild-moderate, cutaneous and resolved without discontinuation of drug.
#RheumTwitter #lupus
Abs#0849 #ACR20 @RheumNow
https://t.co/8a6OcZmOso
Mrinalini Dey DrMiniDey ( View Tweet)
Valerio et al find 40% of 294 patients w/ #rheumaticdisease refuse or are uncertain about getting inactivated #influenza #vaccine. Key determinants of #vaccinehesitancy found to be concerns about adverse events, safety & efficacy.
Abs#0632 #ACR20 @RheumNow
https://t.co/f34DAc5WiN
Mrinalini Dey DrMiniDey ( View Tweet)
In the search for biomarkers in PsA, interesting study showing absolute lymphocyte count is negatively correlated with cardiovascular disease risk score and red cell distribution width and increases with TNF-Inhibitor Therapy @rheumnow #ACR20 Abstr#878
Dr. Antoni Chan synovialjoints ( View Tweet)
Some great abstracts on #vaccine hesitancy in the #infection in #rheumaticdiseases poster session!
What's the greatest concern for patients offered #influenza & #pneumococcal vaccines?
How can we address these concerns & encourage vaccine uptake? Comment below!
#ACR20 @RheumNow
Mrinalini Dey DrMiniDey ( View Tweet)
Tracking CRP in the hyper-acute phase of admission for #COVID19 predictive of progression to critical illness- suggests trends of inflammatory biomarkers, not absolute admission values, may be most useful for triage & therapy.
Abs#0626 #ACR20 @RheumNow
https://t.co/E14y3e4ALi
Mrinalini Dey DrMiniDey ( View Tweet)
Patients with ARDs have incr. susceptibility to #infection. Real-world study shows suboptimal #influenza, #pneumococcal & #herpeszoster #vaccination coverage in these patients. Important to consider strategies to improve uptake.
Abs#0541 #ACR20 @RheumNow
https://t.co/GAapkzILvW
Mrinalini Dey DrMiniDey ( View Tweet)
Dr Rubin of @NEJM on #vaccine development: safety and efficacy very important. Great keynote lecture! @RheumNow #ACR20 https://t.co/hVR2rmOMNp
sheila RHEUMarampa ( View Tweet)
Inflammation is not a single entity, and the imperative to dissect it carefully is so great in irAEs - in both treatment and measurement.
"I'm attempting to stir the pot" - @LCalabreseDO
- and there really is plenty to think about. https://t.co/8C6RbMI2l9
David Liew drdavidliew ( View Tweet)
One of my #ACR20 highlights about to start - irAE Study Group, hosted by @CCalabreseDO & @NohaMDAnderson
Imminent paradigm definition by @LCalabreseDO: one of the biggest challenges in the field: how to target therapies in irAEs, to maintain cancer response
#ACR2020 @RheumNow https://t.co/WzFbCc8TuT
David Liew drdavidliew ( View Tweet)
Dr. Siri will see you now...🤖
Machine learning identified 9 signatures including nail pso, CRP and 7 biomarkers to distinguish PsA from PsO pts without arthritis and will help diagnose PsA early.
➡️will need to test independent data
@RheumNow #ACR20 Abs#0502
Robert B Chao, MD doctorRBC ( View Tweet)
@LCalabreseDO @cappelliMD @MarieKostine @EladSharonMD @rheum_covid For those who missed it, my attempt to capture some of it in a Twitter thread: https://t.co/Z55sV7ZyBt
David Liew drdavidliew ( View Tweet)
@RheumNow #acr20 abs0063 in silico, in vitro &clinical study: Amitriptyline, naloxone& thalidomide prevent NOS2, IL6, IL1B, MMP9 release, inhibits NLRP3 inflammasome pathway> decreased colchicine consumption in gout pts using above meds for other indications #acrbest #different https://t.co/cz3htmtBU0
Olga Petryna DrPetryna ( View Tweet)
